AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05864196 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Two-Fraction Stereotactic Body Radiation Therapy (SBRT)
Description: Two-fraction SBRT with an MRI directed, dominant intraprostatic lesion, simultaneous integrated boost (SIB) based on genomic classification in the treatment of localized prostate cancer.
Study NCT05181735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luspatercept Injection [Reblozyl]
Description: All patients will receive Luspatercept subcutaneously on day 1 of each 21 day cycle (every 3 weeks) at the selected dose according to part A : 1.75mg/kg or 1.33 mg/kg or 0.8 mg/kg
Study NCT05181735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eprex
Description: Epoietin alfa will be adminstered as a subcutaneous injection at the selected dose according to part A : 30 000 UI/week or 60 000 UI/week, every week
Study NCT05481619 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vedolizumab
Description: Recommended dose in patients with UC: 300 mg intravenously at weeks 0, 2, and 6 and every 8 weeks thereafter.~Discontinue vedolizumab at week 14 in patients who do not show treatment benefit.
Study NCT04790513 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: lerodalcibep
Description: anti-PCSK9 small binding protein
Study NCT04790513 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: evolocumab
Description: monoclonal antibody to PCSK9
Study NCT04790513 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: alirocumab
Description: monoclonal antibody to PCSK9
Study NCT05785884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Description: A 6 week randomized diet low in carbohydrates
Study NCT05785884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: USDA Diet
Description: A 6 week randomized diet aligned with USDA recommendations
Study NCT05682651 — intervention group
Intervention type: PROCEDURE
Intervention: tracheal stenosis follow-up file
Description: Patients' age, gender, American Society of Anesthesiologists (ASA) classification, comorbidities, etiologic cause, intubation time, type of surgery, length of hospital stay, and morbidity/mortality information will be recorded.
Study NCT04014140 — intervention group
Intervention type: PROCEDURE
Intervention: Coronary artery bypass grafting surgery (CABG)
Description: Patients with MVCAD will undergo CABG as per standard of care.
Study NCT05804630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Different dental anesthetic agents during wisdom tooth surgery (Orabloc®, Octocaine®, and Xylestesin-A®)
Description: As mentioned in arm/group descriptions. The amount of dental anesthetic agents used during the surgery will be tailored for patient according to their response, which will not exceed the recommended dosage described in the instruction of the product. The amount of the drug used during the surgery will be recorded.
Study NCT05747482 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Surgery procedure
Description: Omentectomy vs omental preservations during gastric surgery
Study NCT06078111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prism 10 + visuo-motor activities
Description: Visuo-motor activities of exploration in the left and right space, adapting activities of daily living, while wearing prisms with 10 degrees of visual field deviation
Study NCT06078111 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neutral Prism + visuo-motor activities
Description: Visuo-motor activities of exploration in the left and right space, adapting activities of daily living, while wearing prisms with no visual field deviation
Study NCT05605132 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive Training Exercise
Description: oculomotor exercises will be applied to the participants three times a week for four weeks.~oculomotor exercises:~* head relocation~* gaze stability~* eye follow~* saccadic eye movement~* head and eye coordination
Study NCT05605132 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tactile Acuity Training
Description: Participants will be requested to lie face down. Five points will be marked in the painful areas on the right and left sides of the neck. The distance between the points will equal the two-point discrimination value. A photograph of the neck will be taken. The patient will not see his/her own neck during the application but see the photograph of his/her neck. The points will be touched lightly with two different stimuli (a pen with a 2 mm diameter and a mushroom probe with an 11 mm diameter). Participants will be asked about the location and type of the stimuli. The interstimulus interval will be 15 seconds. If more than 90% of correct answers are obtained, the distance between the points will be reduced by 10%. The training will be performed in three separate blocks, a total of 72 stimuli (block duration = 6 minutes, rest time between blocks = 3 minutes, number of stimuli applied in each block = 24 stimuli). The treatment time will be 24 minutes.
Study NCT05605132 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: The participants will be evaluated two times at 4-week intervals. No intervention will be applied during the time frame.
Study NCT05870995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CALGE-VEN- RIC-conditioning
Description: Intensive chemotherapy Cladribine-cytarabine-etoposide -venetoclax sequential with fludarabine, busulfan and melphalan or fludarabine and total marrow irradiation
Study NCT05514184 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PLAFOND diet
Description: PLAFOND is a pragmatic patient-centered dietary intervention supported by dietitians who provide education and counseling in the form of Medical Nutrition Therapy (MNT) consisting of 0.6-0.8 g/kg/day dietary protein with >2/3% of the protein from plant-proteins.
Study NCT05514184 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: PLAFOND diet
Description: PLAFOND is a pragmatic patient-centered dietary intervention supported by dietitians who provide education and counseling in the form of Medical Nutrition Therapy (MNT) consisting of 0.6-0.8 g/kg/day dietary protein with >2/3% of the protein from plant-proteins.
Study NCT06015256 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: blood sample
Description: Blood sample (56mL) taken in a heparin tube
Study NCT04990856 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Tumor blood flow after acute exercise
Study NCT05753566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rezvilutamide
Description: Specifications of 80 mg; orally, once a day
Study NCT05753566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Description: Androgen deprivation therapy (ADT), the ADT used by each subject will be determined by the investigator, and the dose and frequency of administration will be consistent with the prescription information
Study NCT05753566 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SRT
Description: SRT according to standard of care (66.6-72 grays will be delivered to the bed of prostate ,\~50.4 grays to the pelvis if needed)
Study NCT06296160 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: A- (Intervention Phase= (Day-1) + (Day-15)~1. Obtain a lung ultrasound after the midweek dialysis session.~2. The 8-zone lung ultrasound method calculates the number of B-line scores.~3. Reduce the dry weight by 500 g if the B-line score is >0.54/zone (BLS>5). considered a day one.~4. The dry weight will be reduced only if the arterial blood pressure at the end of the session is BP >110/60 mmHg and the patient had no hypotension episode during the session.~5. The adjustment of dry weight based on lung ultrasound should not be made on the same day as the standard approach adjustment (Regular monthly clinical standards modification.~6. Check the Blood Pressure 3 times/ day on the non-dialysis following the ultrasound.~7. Check the ambulatory blood pressure for 48 hours (Baseline on day 1 and Follow-up on Day 60).~B - Observational Phase= (Day-30) + (Day-45) + (Day-60)\].
Study NCT05173428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking Cessation Program Based on Transtheoretic Model
Description: Conducting motivational interviews based on the transtheoretic model according to the stages of change that individuals are in.
Study NCT06108648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lavender essential oil 10%, diluted in 90% olive oil
Description: Lavender chest wrap:~Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth.~Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest.~Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.
Study NCT06108648 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Standard care according to national standards.
Study NCT05134103 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindbeacon Therapist Guided, Internet Cognitive Behavioral Therapy for Depression
Description: The treatment consists of 11 depression modules delivered approximately once per week (at therapists' discretion) over a period of 12 weeks. Additionally, the therapist typically tailors treatment to client's individual needs by including supplementary modules for a variety of issues such as generalized anxiety, panic, social anxiety, post-traumatic stress, insomnia, pain, and relationships etc. Clients can complete the readings, exercises, and worksheets at any convenient time, using their web-enabled smartphone, tablet, or computer. Access to the modules and all messaging is provided through the secure platform. Messaging is asynchronous meaning participants can message their therapist as often as they choose and expect a response within 1-2 business days. After 12 weeks of active treatment, they will have unguided access (without therapist support) to the treatment materials that were covered for an additional 40 weeks.
Study NCT05487638 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing Education and Counseling Service Provided to Patients by Video Calling on the Phone
Description: Nursing Education and Counseling Services were provided to the patients by video calling on the phone for the problems they may encounter in the postoperative period.
Study NCT05134103 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Waitlist Control Group
Description: Participants assigned to this arm will wait for 12 weeks before receiving active treatment condition
Study NCT04862598 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oculus Virtual Reality
Description: The patient will receive standard care, augmented with virtual reality. Their post-operative satisfaction score will be recorded.
Study NCT05655000 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neonatal thymus transplantation
Description: The donor's neonatal thymus vessels will be dissected right after the routinary partial thymectomy. These vessels will be anastomosed into the recipient's penetrating vessels within the radial forearm by using a supermicrosurgical technique. The graft will be explanted at day 14-21 after the procedure.
Study NCT05632666 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory and expiratory muscle training at a therapeutic intensity
Description: The active treatment group will receive inspiratory muscle training starting at a therapeutic intensity of 30% of maximum inspiratory mouth pressure (PImax) and expiratory muscle training starting at a therapeutic intensity of 30% of maximum expiratory mouth pressure (PEmax) for 4 months.~In the active treatment group, the inspiratory and expiratory threshold (intensity) will be adjusted to the perceived exertion (measured with a Borg scale).
Study NCT05632666 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Inspiratory and expiratory muscle training at a non-therapeutic intensity
Description: The sham-control group will receive the same training protocol as the active treatment group but with a low (10% of PImax and PEmax) and stable non-therapeutic intensity.
Study NCT05850429 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed
Study NCT05850429 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed
Study NCT05644613 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise on land
Description: aerobic exercise on land in form of walking on the treadmill
Study NCT05644613 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise in water
Description: aerobic exercises in water in form of walking on the treadmill
Study NCT04787835 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Forearm nerve block
Description: Local anesthesia will be used to perform a forearm block of the median, radial, and ulnar nerves.
Study NCT04787835 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthetic infiltration
Description: Local anesthesia will be infiltrated at the site of injury
Study NCT04839211 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Description: Inspiratory muscle training will be performed three sessions per week as one supervised and two unsupervised for 8 weeks using an inspiratory muscle training device (PowerBreath). The inspiratory muscle training session will consist of 7 cycles including a 2:1 ratio of work and rest interval. Resistance will be adjusted to the highest tolerable load and will be gradually increased.
Study NCT04839211 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham inspiratory muscle training
Description: Sham inspiratory muscle training will be performed three sessions per week as one supervised and two unsupervised for 8 weeks using an inspiratory muscle training device (PowerBreath). The inspiratory muscle training session will consist of 7 cycles including a 2:1 ratio of work and rest interval. Resistance will be adjusted to the unloaded.
Study NCT06103227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone 5Mg
Description: Prednisone administered for three weeks. If pregnant women weighs less than 90 kg , she will receive prednisone on altering days instead of every morning for pregnant women weighing more than 90 kg.
Study NCT06103227 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone 5Mg
Description: Prednisone administered for three weeks. If pregnant women weighs less than 90 kg , she will receive prednisone on altering days instead of every morning for pregnant women weighing more than 90 kg.
Study NCT05581095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating Self-Help Program
Description: 10-week exposure to mindful eating principles and practices outlined in the Eat What You Love, Love What You Eat for Binge Eating book
Study NCT05581095 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindful Eating Self-Help Program
Description: 10-week exposure to mindful eating principles and practices outlined in the Eat What You Love, Love What You Eat for Binge Eating book
Study NCT05581095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating Smartphone Application (Am I Hungry? Virtual Coach)
Description: 10-week exposure to using a mindful eating mobile phone application daily.
Study NCT05278884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advanced Cardiac Life Support Training
Description: Advanced Cardiovascular Life Support (ACLS) is a resuscitation course to teach recognition and treatment of cardiopulmonary arrest in patients.
Study NCT05278884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vital Anesthesia Simulation Training
Description: The Vital Anesthesia Simulation Training (VAST) Course focuses on core clinical practices and non-technical skills needed to respond to the most common urgent and emergent clinical challenges found in hospitals in resource-limited settings like Rwanda.
Study NCT06369844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pressure injury education
Description: Pressure injury education will be provided to participants in the intervention group in three separate sessions covering the topics of Pressure Injury Definition and Classification, Risk Assessment, Prevention, and Care.
Study NCT06194695 — intervention group
Intervention type: PROCEDURE
Intervention: drug eluting beads-transcatheter arterial chemoembolization
Description: transcatheter arterial chemoembolization with doxorubicin embedded eluting beads- was performed every 3 weeks through the tumor feeding arteries.
Study NCT06194695 — intervention group
Intervention type: DRUG
Intervention: envatinib plus anti-PD(L)1
Description: oral use of lenvatinib plus intravenous injection of anti-PD(L)1 antibodies. Anti-PD-L1 antibodies includes duravalumab, atezolizumab, or envolizumab, and anti-PD1 antibodies include pembrolizumab, nivolumab, camrelizumab, tislelizumab, sintilimab, or toripalimab.
Study NCT06357455 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cell Salvage Autotransfusion: SAME™ device
Description: * Intervention studied: processing of salvaged blood using the SAME™ autotransfusion device~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Treatment group.~All perioperative measures will be performed according to international, national and in-house standards.
Study NCT06357455 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cell Salvage Autotransfusion: Autolog™ device
Description: * Intervention studied: processing of salvaged blood using the Autolog™ (Medtronic) autotransfusion device (in-house standard device).~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Control group~All perioperative measures will be performed according to international, national and in-house standards.
Study NCT05982366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: distal radial artery acess side
Description: coronary procedure (coronary angiography and/or coronary angioplasty) by the distal radial artery in the anatomical snuffbox area
Study NCT05982366 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional radial artery acess side
Description: coronary procedure (coronary angiography and/or coronary angioplasty) by the forearm radial artery in the anatomical snuffbox area
Study NCT04705389 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Samples
Description: blood samples
Study NCT03040856 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alpha Linolenic Acid
Description: Alpha Linolenic Acid enriched diet
Study NCT03040856 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega 3 enriched diet ( DHA+EPA)
Description: Omega 3 (DHA+EPA) supplementation enriched diet
Study NCT03040856 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules containing olive oil
Study NCT05492513 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Grade 1 CI Therapy +Sensory Components
Description: All participants will receive Grade 1 CI Therapy + Sensory Components over a two-week period of time. The treatment intervention will include all CI Therapy treatment strategies including: 1) supervised motor training in the form of shaping with repeated trials and task practice for 1.5 hours per day for 5 weekdays for 2 weeks 2) a behavioral Transfer Package (TP) will be employed to aid carry-over of skills gained by the participant in the laboratory to the life situation 3) each participant will wear a mitt on the less-affected hand for most of their waking hours to encourage use of the more-affected hand 4) participants will be given home assignments to be carried out for at least 30 minutes each day. Sensory component strategies will be added to stimulate sensory input through the more-affected arm and hand as well as to train sensory discrimination skills.
Study NCT06044805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chloroquine
Description: Total of 25mg base per kg over 3 days (10 mg base/kg on Days 0 and 1, 5 mg base/kg on Day 2)
Study NCT06044805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Primaquine
Description: Primaquine: 7.5 mg base tablet. Medication given as 0.25mg/kg daily for 14 days.
Study NCT05773261 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MobilLINK TrabecuLINK cup
Description: THA with MobilLINK TrabecuLINK cup and LCU stem
Study NCT05773261 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pinnacle Gription cup
Description: THA with Pinnacle Gription cup and Coral stem
Study NCT06480175 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cervical plexus block
Description: patients will receive cervical radiofrequency ablation on both sides then after 2 weeks they will be readmitted and will receive superficial cervical plexus block on one side only
Study NCT06157320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Shen-Fu
Description: Within 24 hours of sepsis diagnosis, patients received a daily intravenous infusion of 100 ml of Shenfu Injection for a continuous duration of 7 days.
Study NCT06157320 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Norepinephrine (NE)，antibiotics，fluid resuscitation
Description: empirical antimicrobial treatment (which is promptly administered after microbial tests), fluid (crystalloids) replacement (to be established according to fluid tolerance and fluid responsiveness), and vasoactive agents (e.g., norepinephrine (NE)), which are employed to maintain mean arterial pressure above 65 mmHg and reduce the risk of fluid overload